Morgan Stanley’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.25M Sell
900,477
-16,243
-2% -$76.7K ﹤0.01% 4186
2025
Q1
$4.21M Sell
916,720
-423,783
-32% -$1.95M ﹤0.01% 4073
2024
Q4
$6.42M Buy
1,340,503
+724,082
+117% +$3.47M ﹤0.01% 3780
2024
Q3
$2.89M Buy
616,421
+119,201
+24% +$559K ﹤0.01% 4398
2024
Q2
$2.81M Sell
497,220
-1,011,428
-67% -$5.71M ﹤0.01% 4335
2024
Q1
$6.2M Sell
1,508,648
-2,537,288
-63% -$10.4M ﹤0.01% 3744
2023
Q4
$17.1M Buy
4,045,936
+2,456,306
+155% +$10.4M ﹤0.01% 3481
2023
Q3
$6.87M Buy
1,589,630
+592,987
+59% +$2.56M ﹤0.01% 3468
2023
Q2
$6.57M Sell
996,643
-252,963
-20% -$1.67M ﹤0.01% 3555
2023
Q1
$8.48M Buy
1,249,606
+465,655
+59% +$3.16M ﹤0.01% 3285
2022
Q4
$5.79M Buy
783,951
+294,678
+60% +$2.18M ﹤0.01% 3621
2022
Q3
$4.83M Sell
489,273
-184,765
-27% -$1.83M ﹤0.01% 3729
2022
Q2
$7.35M Buy
674,038
+261,061
+63% +$2.85M ﹤0.01% 3399
2022
Q1
$4.67M Buy
412,977
+123,588
+43% +$1.4M ﹤0.01% 3765
2021
Q4
$4.54M Buy
289,389
+41,648
+17% +$653K ﹤0.01% 3819
2021
Q3
$4.25M Sell
247,741
-213,794
-46% -$3.67M ﹤0.01% 3906
2021
Q2
$9.93M Buy
461,535
+194,947
+73% +$4.19M ﹤0.01% 2990
2021
Q1
$4.01M Sell
266,588
-630,275
-70% -$9.47M ﹤0.01% 3640
2020
Q4
$11.8M Buy
896,863
+611,313
+214% +$8.03M ﹤0.01% 2335
2020
Q3
$2.76M Buy
285,550
+79,722
+39% +$770K ﹤0.01% 3356
2020
Q2
$2.35M Sell
205,828
-379,144
-65% -$4.34M ﹤0.01% 3445
2020
Q1
$6.06M Sell
584,972
-18,087
-3% -$187K ﹤0.01% 2268
2019
Q4
$9.9M Buy
603,059
+78,490
+15% +$1.29M ﹤0.01% 2443
2019
Q3
$6.97M Sell
524,569
-82,517
-14% -$1.1M ﹤0.01% 2510
2019
Q2
$8.55M Sell
607,086
-20,146
-3% -$284K ﹤0.01% 2335
2019
Q1
$11.5M Sell
627,232
-34,001
-5% -$626K ﹤0.01% 1901
2018
Q4
$17.3M Buy
661,233
+140,884
+27% +$3.68M 0.01% 1586
2018
Q3
$11.9M Sell
520,349
-629,361
-55% -$14.4M ﹤0.01% 2239
2018
Q2
$21.9M Sell
1,149,710
-83,546
-7% -$1.59M 0.01% 1556
2018
Q1
$20.8M Buy
1,233,256
+187,413
+18% +$3.16M 0.01% 1630
2017
Q4
$15.9M Sell
1,045,843
-38,879
-4% -$591K ﹤0.01% 1917
2017
Q3
$19.4M Sell
1,084,722
-99,611
-8% -$1.78M 0.01% 1619
2017
Q2
$19.3M Sell
1,184,333
-410,163
-26% -$6.69M 0.01% 1565
2017
Q1
$22.3M Sell
1,594,496
-192,044
-11% -$2.69M 0.01% 1462
2016
Q4
$28.5M Sell
1,786,540
-55,094
-3% -$879K 0.01% 1239
2016
Q3
$30.6M Sell
1,841,634
-53,681
-3% -$893K 0.01% 1143
2016
Q2
$21.2M Buy
1,895,315
+481,506
+34% +$5.39M 0.01% 1379
2016
Q1
$11.8M Sell
1,413,809
-22,999
-2% -$192K ﹤0.01% 1721
2015
Q4
$13.4M Sell
1,436,808
-136,092
-9% -$1.27M ﹤0.01% 1744
2015
Q3
$17.7M Buy
1,572,900
+115,389
+8% +$1.3M 0.01% 1480
2015
Q2
$18.5M Buy
1,457,511
+36,397
+3% +$462K 0.01% 1569
2015
Q1
$13.2M Sell
1,421,114
-36,604
-3% -$340K ﹤0.01% 1784
2014
Q4
$20.9M Buy
1,457,718
+728,912
+100% +$10.4M 0.01% 1460
2014
Q3
$7.57M Buy
728,806
+37,279
+5% +$387K ﹤0.01% 2277
2014
Q2
$11.2M Buy
691,527
+322,554
+87% +$5.22M ﹤0.01% 1934
2014
Q1
$6M Buy
368,973
+45,565
+14% +$740K ﹤0.01% 2404
2013
Q4
$4.01M Buy
323,408
+159,073
+97% +$1.97M ﹤0.01% 2776
2013
Q3
$1.8M Buy
164,335
+133,491
+433% +$1.46M ﹤0.01% 3315
2013
Q2
$250K Buy
+30,844
New +$250K ﹤0.01% 4711